A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Local Institution - 0008, Halifax, Nova Scotia, Canada

  • Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, GD, China

    Contact: Study coordinator (Jian-Pei Fang) · +862081332199
  • Nanfang Hospital of Southern Medical University, Guangzhou, GD, China

    Contact: Study coordinator (Ling Jiang) · +8613602791429
  • The First People's Hospital of Foshan, Foshan, Guangdong, China

    Contact: Study coordinator (Ying Zhao)
  • Maoming People's Hospital, Maoming Shi, Guangdong, China

    Contact: Study coordinator (Ying Dong)
  • Shenzhen Second People's Hospital, Shenzhen Shi, Guangdong, China

    Contact: Study coordinator (Xin Du)
  • Liuzhou People's Hospital, Liuzhou, Guangxi, China

    Contact: Study coordinator (Liuting LU)
  • People's Liberation Army The 923rd Hospital, Nanning, GX, China

    Contact: Study coordinator (Xiaolin Yin) · +8613321717899
  • Local Institution - 0011, Haikou, Hainan, China

  • Local Institution - 0012, Kunming, Yunnan, China

  • Hainan General Hospital, Haikou, China

    Contact: Study coordinator (Guyun Wang) · +8613006021266
  • The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    Contact: Study coordinator (Yongrong Lai) · +07715356746
  • Local Institution - 0005, Thessaloniki, B, Greece

  • Local Institution - 0018, Rio, G, Greece

  • Local Institution - 0006, Athens, Greece

  • Local Institution - 0009, Goudi, Greece

  • Local Institution - 0007, Larissa, Greece

  • Local Institution - 0025, Hong Kong, HK, Hong Kong

  • Local Institution - 0024, Hong Kong Island, Hong Kong

  • Local Institution - 0022, Cagliari, CA, Italy

  • Local Institution - 0026, Genova, GE, Italy

  • Local Institution - 0020, Orbassano, TO, Italy

  • Local Institution - 0028, Naples, Italy

  • "Universita degli Studi della Campania ""Luigi Vanvitelli"" - AOU - Clinica Pediatrica", Naples, Italy

    Contact: Study coordinator (Silverio Perrotta) · +0390815665421 0 000
  • Hospital Tunku Azizah, Kuala Lumpur, WP, Malaysia

    Contact: Study coordinator (Liana Binti Yusof) · +60137440025
  • Hospital Sultanah Aminah, Johor Bahru, Malaysia

    Contact: Study coordinator (Christopher Chin Keong Liam) · +60127069245
  • Local Institution - 0035, Al-Ahsa, Saudi Arabia

  • King Saud University (KSU) - College of Medicine, Riyadh, Saudi Arabia

    Contact: Study coordinator (Sarah Sewaralthahab) · +966014671504
  • KK Women's and Children's Hospital, Singapore, Singapore

    Contact: Study coordinator (Joyce Ching Mei Lam) · +6562255554
  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, KHH, Taiwan

    Contact: Study coordinator (Shyh-Shin Chiou)
  • National Taiwan University Hospital, Nan Gang Qu, TPE, Taiwan

    Contact: Study coordinator (Meng-Yao Lu) · +88622312345671713
  • China Medical University Hospital, Taichung, TXG, Taiwan

    Contact: Study coordinator (Ching-Tien Peng) · 886422052121ext4636
  • Siriraj Hospital, Bangkok Noi, Bangkok, Thailand

    Contact: Study coordinator (Vip Viprakasit) · 6624122113
  • Naresuan University Hospital, Mueang Phitsanulok, Thailand

    Contact: Study coordinator (Peerapon Wong) · +6655965105
  • Hacettepe Üniversitesi Tıp Fakültesi, Altındağ, Turkey (Türkiye)

    Contact: Study coordinator (Sule Unal) · +903123112398
  • Istanbul Universitesi - Istanbul Tip Fakultesi (ITF) Hastanesi, Topkapı, Turkey (Türkiye)

    Contact: Study coordinator (Zeynep Karakas) · +902124142000
Study leads
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb